Erasca (ERAS) Non-cash Items (2020 - 2026)
Erasca (ERAS) reported Non-cash Items of $28.7 million for Q1 2026, up 45.79% on a YoY basis from $19.7 million in Q1 2025, and down 53.44% quarter-over-quarter from $61.7 million in Q4 2025.
Erasca (ERAS) Non-cash Items (2020 - 2026) Analysis & Trends
Erasca has reported Non-cash Items for 7 years, with the latest figure at $28.7 million in Q1 2026.
- For the quarter ending Q1 2026, Non-cash Items rose 45.79% year-over-year to $28.7 million; the trailing twelve-month figure through Mar 2026 stood at $28.7 million (up 45.79% YoY), and the FY2025 full-year result was $61.7 million, up 374.7% from the prior year.
- Non-cash Items for Q1 2026 stood at $28.7 million, down from $61.7 million in the prior quarter.
- The five-year high for Non-cash Items was $62.5 million in Q2 2023, with the low at $880000.0 in Q2 2025.
- Historically, Non-cash Items has averaged $22.1 million across 5 years, with a median of $16.8 million in 2024.
- Annual changes were most pronounced in 2022 — Non-cash Items soared 1513.67% — and 2025, when it plunged 94.19%.
- Erasca's Non-cash Items stood at $18.3 million in 2022, then sank by 75.88% to $4.4 million in 2023, then soared by 194.4% to $13.0 million in 2024, then surged by 374.7% to $61.7 million in 2025, then sank by 53.44% to $28.7 million in 2026.
- The last three Non-cash Items figures came in at $28.7 million (Q1 2026), $61.7 million (Q4 2025), and $24.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Erasca | 4.16 Bn | 3.92 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.71 Mn |
| Mar 31, 2026 | 28.71 Mn |
| Dec 31, 2025 | 61.66 Mn |
| Dec 31, 2025 | 61.66 Mn |
| Sep 30, 2025 | 24.44 Mn |
| Sep 30, 2025 | 24.44 Mn |
| Jun 30, 2025 | 880,000.00 |
| Jun 30, 2025 | 880,000.00 |
| Mar 31, 2025 | 19.69 Mn |
| Mar 31, 2025 | 19.69 Mn |
| Dec 31, 2024 | 12.99 Mn |
| Dec 31, 2024 | 12.99 Mn |
| Sep 30, 2024 | 16.77 Mn |
| Sep 30, 2024 | 16.77 Mn |
| Jun 30, 2024 | 15.16 Mn |
| Jun 30, 2024 | 15.16 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Mar 31, 2024 | 7.53 Mn |
| Dec 31, 2023 | 4.41 Mn |
| Dec 31, 2023 | 4.41 Mn |